Weight-loss drugs are priced substantially higher in the U.S. than in other countries, analysis says
Publishing timestamp: 2023-08-17 16:58:00
Summary
Blockbuster weight-loss drugs are priced significantly higher in the U.S. compared to other large, high-income countries. Many U.S. health insurers are dropping weight-loss medications from their plans due to the extreme cost. The prices of these drugs are straining insurers' budgets, and many obese Americans cannot afford to pay out of pocket for the treatments. The list prices of these drugs vary greatly between countries, with the U.S. having the highest prices. The lack of direct negotiation between drugmakers and the U.S. contributes to the disparity in prices. The high prices and limited insurance coverage affect the accessibility and interest in weight-loss medications. New trial data from Novo Nordisk suggests that these drugs have significant health benefits beyond weight loss, potentially putting more pressure on U.S. insurers to cover them. However, insurers are requesting more data before expanding coverage.
Sentiment: NEUTRAL
Keywords: business news, biotech and pharmaceuticals, business, biotechnology, novo nordisk a/s, breaking news, pharmaceuticals, eli lilly and co, united states, japan, health care industry,
Source: https://www.cnbc.com/2023/08/17/weight-loss-drugs-cost-more-in-us-kff-says.html